oral serine _-lactamase inh. prodrug

restores ceftibuten activity in model, Ph. I

hydrolysis transition state mimetic

Journal of Medicinal Chemistry

Venatorx Pharmaceuticals, Malvern, US

11. The Venatorx serine _-lactamase inhibitor VNRX-7145 is an orally bioavailable prodrug of the boronic acid-containing inhibitor VNRX-5236, and is currently in Ph. I. It demonstrates activity in vitro…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.